Health-care providers wrote more than 9 million prescriptions for Ozempic and similar drugs in the final three months of 2022, according to a new analysis of medications that have become highly ...

A diabetes medication in short supply for the last two years often was prescribed to people who didn't have the disease, and prescribing rates varied dramatically across the country, new data shows.

You don't often see a "science day" in a Philadelphia courtroom. But that's exactly what happened last week in a potentially ...

A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat diabetes says the drugmaker didn’t ...

Some patients taking weight-loss drugs, like Ozempic, are beginning to report slower or no weight loss as their bodies build ...

Analysts believe Hims & Hers will earn $0.57 per share this year and $0.80 next year. That prices the stock at 17 times next ...

Plus: GLP-1 drugs like Ozempic have potential to treat cancer, COVID-19, heart disease, and many other diseases.

Inflation might be easing in some segments of the economy, but health care costs are set to soar next year ... increased expenditures on specialty prescription drugs — particularly GLP-1 ...

Businesses can take proactive steps now to best position themselves for a competitive advantage in the face of the seismic ...

The CEO of Novo Nordisk is defending the high cost of Ozempic and Wegovy in America, saying the blockbuster drugs are ultimately saving taxpayers money on obesity-related costs.

(NEXSTAR) – A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat ... runny nose and sore throat. While other gastrointestinal issues are mentioned in the 15-page ...